UK Antibacterial (Antibiotics) Drugs Market Analysis

UK Antibacterial (Antibiotics) Drugs Market Analysis


$ 3999

UK Antibacterial (Antibiotics) Drugs Market is at around $1.32 Bn in 2023 and is projected to reach $1.54 Bn in 2030, exhibiting a CAGR of 2.2% during the forecast period. The market is growing due to factors such as the aging population, rising prevalence of infectious diseases, and technological advancements. The market is dominated by key players like Wockhardt UK Ltd, Teva Pharmaceuticals Industries Ltd, AstraZeneca plc, Pfizer Inc., Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.

ID: IN10GBPH005 CATEGORY: Pharmaceuticals GEOGRAPHY: UK AUTHOR: Aneri Parekh

Buy Now

UK Antibacterial (Antibiotics) Drugs Market Executive Summary

UK Antibacterial (Antibiotics) Drugs Market is at around $1.32 Bn in 2023 and is projected to reach $1.54 Bn in 2030, exhibiting a CAGR of 2.2% during the forecast period.

Treating illnesses caused by bacteria in the UK is the focus of the antibiotics market in the country. This market includes a broad spectrum of antibiotic medications, including those that treat common infections like skin, urinary tract, and respiratory infections. To effectively navigate this vital sector, players must have a thorough understanding of market trends and difficulties.

Growing awareness of antibiotic resistance and rising rates of bacterial infections are driving the UK antibiotics market, which is still growing. To address the issue of resistance and provide new formulations, major firms are concentrating on research and development. The market environment is shaped by government programs encouraging prudent antibiotic usage and strict regulatory restrictions. Effective antibiotic stewardship and long-term market growth require cooperation between pharmaceutical corporations and healthcare providers.

There has been a noticeable change in the antibiotic sector in recent years. Revenue from the market reached $50.91 Bn in 2023 and is anticipated to grow further. Infectious diseases and the development of new products are the main factors contributing to this expansion. The need for new antimicrobial formulations, increased R&D, and antibiotic prescriptions have all contributed to these advances. New antibiotics and urbanization have an impact on market expansion.

Wockhardt UK Ltd is the UK's leading generic pharmaceutical company, specializing in the production and distribution of generic and branded antibiotics. A wide range of medications, including aminoglycosides, macrolides, penicillin, cephalosporins, and fluoroquinolones, are available from Wockhardt UK Ltd. It offers contract manufacturing services, including antibiotic production, for other pharmaceutical firms in addition to their pharmaceuticals. With the opening of a new sterile production facility in Wrexham, North Wales, Wockhardt UK Ltd. has made major investments to increase its manufacturing capabilities in the UK. It is anticipated that this investment will help them further solidify their position in the UK antibiotics market.

UK antibacterial (antibiotics) drugs market

Market Dynamics

Market Growth Drivers:

Increasing Prevalence of Infectious Diseases: Antibiotic demand in the UK is driven by growing bacterial infections and drug-resistant strains. Pneumonia, urinary tract infections, and STDs continue to drive drug needs.

Aging Population: Due to reduced immune systems and comorbidities, the elderly are more susceptible to infections and need antibiotics more often. 11 Mn people in the UK are aged 65 or older.

Technological Advancements: Novel antibiotic formulations, greater potency, and decreased side effects boost market growth. Combination medicines and innovative drug delivery technologies improve antibiotic treatment, expanding the market.

Market Restraints:

Regulatory Issues: New antibiotic approval restrictions can hinder market expansion as it is complicated and expensive, requiring significant clinical trials and compliance with the UK regulatory criteria.

Treatment Alternatives: The availability of vaccinations and non-antibiotic therapy for certain infections may reduce antibiotic use. Proactive antibiotic stewardship and prudent antibiotic use could further reduce antibiotic consumption, affecting market growth.

Patent Expiration: After major antibiotic patents expire, generic producers may increase competition, putting pressure on branded antibiotic prices and market share. Pharmaceutical corporations may lose money and spend less on antibiotic development.

Healthcare Policies and Regulatory Landscape

Medical equipment, medications, and blood components are regulated in the UK by the Medicines and Healthcare Products Regulatory Agency (MHRA). The executive agency known as MHRA is sponsored by the Department of Health and Social Care. The regulatory agency reviews clinical research to make sure the drug is safe, effective, and meets manufacturing quality standards. If they are satisfied, a license or marketing authorization is given. This enables the license holder to offer the product for sale in the regions under the regulatory body's jurisdiction. Thorough regulatory assessments, extensive clinical trials, and adherence to the stringent safety and efficacy requirements set forth by the Medicines and Healthcare Products Regulatory Agency (MHRA). It takes a lot of time and resources to complete these processes, which occasionally results in delays and challenges when new drugs are introduced to the market.

Competitive Landscape

Key Players:

  • Wockhardt UK Ltd
  • Teva Pharmaceuticals Industries Ltd
  • AstraZeneca plc
  • Pfizer Inc.
  • Roche
  • Novartis AG
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sanofi S.A.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UK Antibacterial (Antibiotics) Drugs Market Segmentation

By Drug Class

  • Cephalosporins
  • Penicillin
  • Fluoroquinolone
  • Macrolides
  • Carbapenems
  • Aminoglycosides
  • Sulfonamides
  • 7-ACA
  • Others

By Type

  • Branded Antibiotics
  • Generic Antibiotics

By Action Mechanism

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors
  • Others

By Spectrum

  • Broad-spectrum Antibiotic
  • Narrow-spectrum Antibiotic

By Administration

  • Oral
  • Intravenous
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 26 February 2024
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up